NYC Life Sciences Fund

NYC Life Sciences Fund

The NYC Life Sciences Fund was established at an undisclosed date, with a name that signals a focus on the life sciences cluster anchored by New York City's research hospitals and universities. Its offices in Princeton, Chicago, Shanghai, and Beijing imply a strategy that taps both the US East Coast and Chinese biotech ecosystems, though the fund's exact founding year and founding principals are not public. Investment strategy centers on early-stage life sciences — likely spanning drug development, diagnostics, and medical devices. The geographic footprint from Princeton to Shanghai suggests the fund backs companies with translational science from academic institutions, and may engage in cross-border syndicates. No named portfolio companies or co-investors have been publicly identified. The fund's stage coverage concentrates on seed and Series A rounds, typical of venture-style life sciences vehicles. Team size and total deployment are not disclosed. The fund maintains four offices, which is unusual for a single-region-focused vehicle and hints at a distributed operational model. No philanthropic arms or adjacent vehicles have been associated with the fund. As of 2025, no recent operational events have been reported. A structural differentiator is the fund's explicit naming after a city while operating multiple international offices — suggesting it functions more as a global life sciences venture fund than a geographically constrained one. This gap between name and footprint may reflect regulatory or branding decisions rather than investment scope.